Nisha Nagarsheth
- Oncology top 1%
- Molecular Biology top 5%
- Immunology top 1%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 5%
- Topics
- CAR-T cell therapy research (6 papers)Cancer Immunotherapy and Biomarkers (5 papers)Immunotherapy and Immune Responses (4 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesChinaPoland
In The Last Decade
Nisha Nagarsheth
16 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 2.4k
- Molecular Biology 2.3k
- Immunology 1.8k
- Cancer Research 644
- Pulmonary and Respiratory Medicine 594
Countries citing papers authored by Nisha Nagarsheth
This map shows the geographic impact of Nisha Nagarsheth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nisha Nagarsheth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nisha Nagarsheth more than expected).
Fields of papers citing papers by Nisha Nagarsheth
This network shows the impact of papers produced by Nisha Nagarsheth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nisha Nagarsheth. The network helps show where Nisha Nagarsheth may publish in the future.
Co-authorship network of co-authors of Nisha Nagarsheth
This figure shows the co-authorship network connecting the top 25 collaborators of Nisha Nagarsheth. A scholar is included among the top collaborators of Nisha Nagarsheth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nisha Nagarsheth. Nisha Nagarsheth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 11 | |
| 3 | 13 | |
| 4 | 33 | |
| 5 | 9 | |
| 6 | 4 | |
| 7 | Chemokines in the cancer microenvironment and their relevance in cancer immunotherapybreakdown → | 1561 |
| 8 | Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagybreakdown → | 1572 |
| 9 | 14 | |
| 10 | 213 | |
| 11 | Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapybreakdown → | 893 |
| 12 | 31 | |
| 13 | 2 | |
| 14 | 297 | |
| 15 | 159 | |
| 16 | 1 |
About Nisha Nagarsheth
Nisha Nagarsheth is a scholar working on Virology, Immunology and Oncology, having authored 16 papers that have together received 4.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Oncology (2.4k citations), Immunology (1.8k citations) and Cancer Research (644 citations). Nisha Nagarsheth has collaborated with scholars based in United States, China and Poland. Frequent co-authors include Weiping Zou, Max S. Wicha, Ilona Kryczek, Jing‐Yuan Fang, Danfeng Sun, Jie Hong, Haoyan Chen, Dan Ma, Fangfang Guo and Yingxuan Chen. Their work appears in journals such as Nature, Cell and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.